Skip to Content

Nymox Pharmaceutical Corp

Rating as of

Company Profile

Business Description

Nymox Pharmaceutical Corp is a biopharmaceutical company. The firm and its subsidiaries specialize in research and development of drugs and diagnostic products for the aging population. Its product portfolio consists of Nic alert and Tobac alert. The firm has Research and development of products for the aging population reportable segment. It operates mainly in Canada, the United States and Europe and other countries. The company generates a majority of its sales from the United States.

Contact
Bay & Deveaux Streets
Nassau, Bahamas
T +1 800 936-9669
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type
Employees 4